• 3D Systems (NYSE:DDD) formed a new, wholly owned company called Systemic Bio, a biotech company focused on the application of advanced bioprinting technologies to pharmaceutical drug discovery and development. Systemic Bio will leverage 3D Systems’ breakthrough, production-level bioprinting technology to create extremely precise vascularized organ models using biomaterials and human…

    Read More
  • Darling Ingredients’ Health Brand, Rousselot, the global leader in collagen-based solutions, and Gelomics, the world-leading provider of fully integrated 3D cell, organoid and tissue culture technologies, have entered into a co-branding partnership. Rousselot Biomedical will supply Gelomics with its X-Pure GelMA (gelatin methacryloyl), a photo cross-linkable extracellular matrix, for use…

    Read More
  • The risk has never been higher than in recent times as brave and passionate entrepreneurs attempt to pave the way for this new world of three-dimensional (3D) lab-grown cell cultivated, plant-based & hybrid meat, fish, and other food alternatives. The demand for alternative meat and the removal of animals from…

    Read More
  • Carl Zeiss Meditec and Precise Bio to develop fabricated corneal tissue. For transplants in patients that require endothelial keratoplasty.

    Carl Zeiss Meditec, one of the world’s leading medical technology companies, and Precise Bio, a regenerative medicine company advancing the use of bio-printed tissues and organs, have entered into a partnership to develop and commercialize fabricated corneal tissue for transplants in patients that require endothelial keratoplasty and natural lenticule transplants…

    Read More
  • Humabiologics partners with Fisher Scientific. To distribute human biomaterials for regenerative medicine research.

    Humabiologics, an industry leader in providing human-derived biomaterials for regenerative medicine, founded by scientists and tissue industry experts to address the gap between the gift of donated human tissues and researchers, and Fisher Scientific, a global leader in life sciences, are partnering to serve researchers in academia and industry who…

    Read More
  • Ouro Foods is researching advanced 4D tissue engineering technologies to biofabricate plant- and cell-based food for health applications. Led by Chief Executive Officer Dr. Elizabeth Bennett, Chief Technology Officer Dr. Hakan Gurbuz, and Chief Culinary Officer Craig Dewar (professional chef), the company’s vision is to create a new, customizable protein…

    Read More
  • When the larger public imagines bioprinting they tend to imagine a machine that builds cellular tissues adding one cell after the other. Generally, that’s not the case, as most technologies leverage bioinks and hydrogels to create scaffolds and deposit the cellular materials. Fluicell’s microfluidic bioprinting technology first delivered single-cell printing…

    Read More
  • Finnish bioprinting startup Brinter released the new extrusion-based Visco Bio medical print head for its Brinter bioprinters. The new modular print heads enable nearly zero dead volume, meaning that expensive medical grade material waste is cut to a minimal level. The Finnish company continues to develop and implement new features…

    Read More
  • A team from Utrecht University (Netherlands), working on novel 3D bioprinting technologies and on their application in medicine and biomedical research, just published a new study on volumetric bioprinting of large-scale, functional liver units. The study, titled “Volumetric Bioprinting of Organoids and Optically Tuned Hydrogels to Build Liver-Like Metabolic Biofactories”,…

    Read More
  • A new company has emerged that is targeting the goal of bioprinting kidney tissue (and eventually kidney organs) for implantation. Trestle Biotherapeutics, a private company based in San Diego, has entered into a license agreement with Harvard University. Under the agreement, Trestle will commercialize a suite of stem cell- and…

    Read More
Back to top button

We use cookies to give you the best online experience and for ads personalisation. By agreeing you accept the use of cookies in accordance with our cookie policy.

Privacy Settings saved!
Privacy Settings

When you visit any web site, it may store or retrieve information on your browser, mostly in the form of cookies. Control your personal Cookie Services here.

These cookies are necessary for the website to function and cannot be switched off in our systems.

In order to use this website we use the following technically required cookies
  • wordpress_test_cookie
  • wordpress_logged_in_
  • wordpress_sec

Decline all Services
Accept all Services



Join industry leaders and receive the latest insights on what really matters in AM!

This information will never be shared with 3rd parties

I’ve read and accept the privacy policy.*